Related Experiment Video
Updated: May 14, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
Published on: September 21, 2019
Insight into the medicinal chemistry of the endocannabinoid hydrolase inhibitors
C N Kapanda1, J H Poupaert, D M Lambert
1Medicinal Chemistry, Cannabinoid and Endocannabinoid Research Group, B1.73.10, Louvain Drug Research Institute (LDRI), Université catholique de Louvain, 73 avenue E. Mounier B-1200 Bruxelles, Belgium.
Abstract:
Endocannabinoid hydrolases are nowadays increasingly considered as potential therapeutic targets for treating several pathological states. So far, numerous classes of endocannabinoid hydrolase inhibitors have been described. We herein review the medicinal chemistry of these inhibitors with a particular emphasis on the basis of their design, chemical structure, structure-activity relationships, and inhibition mechanisms.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Pharmacogenomics: Identification of New Drug Targets
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Discovery: Overview
Analgesia and Pain Management

